Geneva Capital Management Trims Novanta Stake

Institutional investor reduces holding in technology company by 1%

Mar. 11, 2026 at 11:40am

Got story updates? Submit your updates here. ›

Geneva Capital Management LLC, an institutional investor, has reduced its stake in Novanta Inc. (NASDAQ:NOVT) by 1.0% during the third quarter, according to a recent SEC filing. The firm now owns 979,038 shares of the technology company's stock, accounting for approximately 2.74% of its portfolio.

Why it matters

Novanta is a global technology company that provides precision components and software for advanced photonics and motion control applications, primarily serving the medical device and industrial markets. Changes in institutional ownership can provide insights into investor sentiment and the stock's performance outlook.

The details

According to the filing, Geneva Capital Management sold 9,931 shares of Novanta during the third quarter. The firm now owns a total of 979,038 shares, worth approximately $98 million based on the stock's current trading price. Novanta accounts for 1.7% of Geneva Capital Management's overall investment portfolio, making it the 17th largest holding.

  • The share sale occurred during the third quarter of the company's fiscal year.

The players

Geneva Capital Management LLC

An institutional investment firm that manages a portfolio of equity and fixed-income securities.

Novanta Inc.

A global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications, primarily serving the medical device and industrial markets.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Geneva Capital Management's Novanta stake, while relatively small, could signal a shift in investor sentiment towards the technology company. Analysts will likely monitor Novanta's performance and any further changes in institutional ownership to gauge the stock's outlook.